MaxCyte, Inc. (MXCT) Free cash flow 2019–2025
MaxCyte, Inc. (MXCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$36.2MFY2025 · since FY2019: -$10.1M → -$36.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.2M | -23.6% |
| FY2024 | -$29.3M | -15.3% |
| FY2023 | -$25.4M | +23.7% |
| FY2022 | -$33.3M | -129.2% |
| FY2021 | -$14.5M | -33.7% |
| FY2020 | -$10.9M | -7.7% |
| FY2019 | -$10.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MXCT financial trends
MXCT RevenueMXCT Net incomeMXCT Net marginMXCT Gross profitMXCT Gross marginMXCT Operating incomeMXCT Operating marginMXCT Operating cash flowMXCT Capital expendituresMXCT Return on equityMXCT Stock buybacksMXCT Dividends paidMXCT Total assetsMXCT Total liabilitiesMXCT Shareholders’ equityMXCT overview →